HRAS and prostate carcinoma: In contrast, the overexpression of TMEM176B led to decreased proliferation of the androgen-sensitive LNCaP prostate cancer cell line and reduced the growth of NIH3T3 cells transfected with constitutively active H-Ras [17,18].